Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

Convincing data have shown that human papillomavirus (HPV)-DNA testing predicts the development of high-grade cervical cancer better than cytology. However, for HPV-positive women, triage with ...

TUCSON, Ariz., June 16, 2015 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the publication of further results from the Primary ASC-US LSIL ...

Next-generation biomarker cytology test supports World Health Organization’s goal to eliminate cervical cancer, which is nearly 100 percent preventable with proper screening, vaccination and treatment ...

DUBLIN--(BUSINESS WIRE)--The "Global Cytology Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The cytology market will register a CAGR of nearly 7% by 2022. The screening ...

CINtec ® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, N.J., Feb. 9, 2023 /PRNewswire/ -- BioReference® Health LLC, one of the largest full-service ...

IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma. Background: Cerebrospinal ...

The findings of a new study add to growing evidence that cotesting may offer limited clinical value despite its common use in ...

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global cytology market to grow at a CAGR of close to 7% during the forecast period, according to their latest market research report. The ...